3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
3
Recruiting
1
Sponsor Class
INDUSTRY
4
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Papillomavirus Infections
1
Interventions
Specimen Handling
115
Magnetic Resonance Spectroscopy
77
Biopsy
69
Cyclophosphamide
24
pembrolizumab
22
Cisplatin
21
fludarabine
18
Platinum
17
1,2-diaminocyclohexaneplatinum II citrate
17
Taxes
16
Paclitaxel
16
Carboplatin
16
Nivolumab
15
Immunoglobulin G
14
Disulfides
14
X-Rays
13
Radiation
13
Doxorubicin
12
venetoclax
11
Radiotherapy
11
Gemcitabine
11
durvalumab
9
cabozantinib
8
aldesleukin
8
Prednisone
8
atezolizumab
7
Cytarabine
7
olaparib
6
lutetium Lu 177 dotatate
6
gallium Ga 68 dotatate
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
NIH
×
Human Papillomavirus DNA Tests
×
Clear all
NCT07281430
2026-05-13
LMI-001-A-S04
National Cancer Institute (NCI)
Phase NA
Recruiting
500 enrolled